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Abstract The base excision repair machinery protects
DNA in cells from the damaging effects of oxidation,
alkylation, and deamination; it is specialized to fix single-
base damage in the form of small chemical modifications.
Base modifications can be mutagenic and/or cytotoxic,
depending on how they interfere with the template function
of the DNA during replication and transcription. DNA
glycosylases play a key role in the elimination of such
DNA lesions; they recognize and excise damaged bases,
thereby initiating a repair process that restores the regular
DNA structure with high accuracy. All glycosylases share a
common mode of action for damage recognition; they flip
bases out of the DNA helix into a selective active site
pocket, the architecture of which permits a sensitive
detection of even minor base irregularities. Within the past
few years, it has become clear that nature has exploited this
ability to read the chemical structure of DNA bases for
purposes other than canonical DNA repair. DNA glyco-
sylases have been brought into context with molecular
processes relating to innate and adaptive immunity as well
as to the control of DNA methylation and epigenetic
stability. Here, we summarize the key structural and
mechanistic features of DNA glycosylases with a special
focus on the mammalian enzymes, and then review the
evidence for the newly emerging biological functions
beyond the protection of genome integrity.
Introduction
The integrity of genetic information is under constant threat
by the tendency of DNA to engage in chemical reactions in
its cellular environment. These can damage the DNA in
various ways, most frequently by oxidation, alkylation, or
deamination of the coding bases (Lindahl and Wood 1999).
Damage to DNA bases may affect their base-pairing
properties and, therefore, needs to be fixed to maintain the
template function of the DNA (Kunz et al. 2009a). Many
base lesions are pro-mutagenic, i.e., they give rise to
genetic mutations if not repaired. One such example is
7,8-dihydro-8-oxoguanine (8-oxoG), a frequent product of
DNA oxidation. 8-oxoG tends to base-pair with adenine,
thus giving rise to G•C to T•A transversion mutations.
Likewise, hydrolytic deamination of cytosine and 5-
methylcytosine (5-meC) gives rise to uracil and thymine
mispaired with guanine, respectively, causing C•G→T•A
transition mutations if not repaired. Alkylation can generate
a variety of DNA base lesions comprising O6-
methylguanine (6-meG), N7-methylguanine (7-meG), or
N3-methyladenine (3-meA). While 6-meG is pro-
mutagenic by its property to pair with thymine, 7-meG
and 3-meA block replicative DNA polymerases and are
therefore cytotoxic (Lindahl and Wood 1999).
These and many other forms of DNA base damage arise
in cells at least 10,000 times every day and only the
continuous action of specialized DNA repair systems can
prevent a rapid decay of genetic information. Single-base
lesions are eliminated by base excision repair (BER), a
pathway initiated by DNA glycosylases that recognize and
excise damaged bases. Base removal by a DNA glycosylase
generates a so-called apurinic/apyrimidinic site (AP-site) in
DNA, which is then further processed by specific AP-
endonuclease, DNA polymerase, and DNA ligase activities
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to restore the original DNA sequence (Fig. 1) (Almeida and
Sobol 2007). Accordingly, cells lacking DNA glycosylase
functions generally show increased levels of base damage in
their DNA, elevated mutation rates, and hypersensitivity to
specific DNA damaging agents. Surprisingly, however, the
phenotype of DNA glycosylase disruptions in mice is usually
rather moderate (reviewed in Robertson et al. 2009), the only
known exception being the thymine DNA glycosylase
(TDG), which was recently reported to be essential for
embryonic development in mouse (Cortazar et al. 2011;
Cortellino et al. 2011).
In this review, we will focus on the mammalian DNA
glycosylases, for which we will briefly summarize the key
structure–function concepts and discuss their role in the
repair of DNA base lesions. We will further elaborate on
their newly emerging functions beyond canonical DNA
repair, e.g., in innate and adaptive immunity and in DNA
methylation control.
DNA glycosylases—an ancient family of DNA repair
proteins
The consideration that cells must possess an ability to
remove uracil from DNA, which arises either by misincor-
poration of deoxyuridine monophosphate (dUMP) during
DNA replication or by hydrolytic deamination of cytosine,
led to the discovery of an enzyme capable of cleaving
uracil–deoxyribose bonds, the uracil N-glycosidase (Ung)
in Escherichia coli (Lindahl 1974). This finding was
followed by the isolation of many other DNA glycosylases
in species from all kingdoms of life. Eleven DNA
glycosylases have been identified in mammals and these
can be subdivided into four structurally distinct super-
families; the uracil DNA glycosylases (UDGs), the helix-
hairpin-helix (HhH) glycosylases, the 3-methyl-purine
glycosylase (MPG), and the endonuclease VIII-like (NEIL)
glycosylases (Table 1).
The uracil DNA glycosylases
E.coli Ung turned out to be the founding member of a large
superfamily of glycosylases, which now includes six
subfamilies, three of which are present in the eukarya.
Besides the UNG subfamily, these include the mismatch-
specific uracil DNA glycosylases (MUGs) (Gallinari and
Jiricny 1996) and the single-strand-specific monofunctional
uracil DNA glycosylases (SMUGs) (Haushalter et al.
1999). Despite a considerable amino-acid sequence diver-
gence, all UDGs share a common alpha–beta fold struc-
tured catalytic domain (Aravind and Koonin 2000).
Members of the UNG subfamily have been characterized
in organisms from bacteria and yeasts to humans and large
Fig. 1 The core pathway short-patch BER. The base-excision repair
pathway addresses single-base lesions (a). BER is initiated by a DNA
glycosylase, e.g., UNG, specifically recognizing and binding a base
lesion. Upon encountering a substrate base, e.g., uracil for UNG, the
glycosylase flips the base out of the base-stack into its catalytic site
pocket where specific contacts examine the substrate base and position
it for nucleophilic attack to the N-glycosidic bond (b). Release of the
substrate base results in an abasic site (c), which is further processed
by the AP-endonuclease, APE1, that cleaves the phosphate backbone
5’ to the abasic site, producing a 3’OH and a 5’deoxyribose-phosphate
moiety (5’dRP) (d). Polymerase β (Polβ) hydrolyzes the 5’dRP and
fills in the single nucleotide gap, which is subsequently sealed by the
DNA ligase III (LigIII), supported by the scaffold protein XRCC1 (e),
thus restoring the original base sequence (f). The increase of DNA
bending from UNG to Polβ might support the directionality of the
handover from one BER factor to the next
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"eukaryotic" viruses. These are highly conserved both at the
amino-acid sequence and gene structure levels; the yeast
and human proteins share 40.3% amino-acid sequence
similarity and the human, mouse, and fish genes have
identical exon–intron boundaries, indicating that the exon–
intron organization has not changed for more than
450 million years (Krokan et al. 1997). Alternative splicing
as well as transcription from two distinct start sites gives
rise to the specific mitochondrial and nuclear isoforms
UNG1 and UNG2 in mouse and human cells (Nilsen et al.
1997). UNG is highly specific for processing of uracil in
DNA but also excises DNA-incorporated 5-fluorouracil (5-
FU), a uracil analog used in cancer therapy (Pettersen et al.
2011). Interactions with PCNA and RPA target the nuclear
UNG2 to sites of DNA synthesis, where its main function is
to rapidly excise uracil that gets incorporated opposite from
adenine (Otterlei et al. 1999). Accordingly, mouse cells
deficient in UNG accumulate ~100-fold increased levels of
uracil in their DNA but, notably, do not show a significant
mutator phenotype (Nilsen et al. 2000). This is unlike
human cells where inhibition of UNG appears to elevate the
mutation frequency mildly (Radany et al. 2000). However,
mice lacking Ung do develop B-cell lymphomas and show
disturbances of antibody diversification, implicating a
specific function of UNG in processing deamination-
induced U•G mismatches at immunoglobulin loci to
facilitate somatic hypermutation and class switch recombi-
nation (Rada et al. 2002; Nilsen et al. 2003). Consistently,
mutations in the human UNG gene have been associated
with a subgroup of hyper-IgM syndrome patients, showing
impaired class switch recombination (Imai et al. 2003).
The MUG subfamily of UDGs emerged with the identifi-
cation of TDG, an enzyme capable of excising thymine from
G•Tmismatches. Nonetheless, the family was named after the
E.coli Mug protein (Gallinari and Jiricny 1996), giving
credit to the fact that the G•U rather than the G•T mismatch
represents the common most efficiently processed substrate
for the members of this subfamily. MUG orthologs have
been described in Schizosaccharomyces pombe, Drosophila
melanogaster (Hardeland et al. 2003), and mammals
Table 1 Mammalian DNA glycosylases, their main substrates, modes of action, and mutant phenotypes
Type of base lesion Name Physiological
substrates
Mono
(M)/ bi(B)
functional
Mouse knockout (ko)/
knockdown (kd) phenotype
Uracil in ssDNA
dsDNA
UNG Uracil-N glycosylase U, 5-FU, ss and
dsDNA
M ko: viable, B-cell lymphomas,
disturbed antibody diversification
SMUG1 Single-strand-specific
monofunctional uracil
DNA glycosylase 1
U, 5–hmU, 5-FU,
ss and dsDNA
M kd: moderate increase in mutation
frequency (C→T)
Pyrimidine derivates
in mismatches
MBD4 Methyl-binding domain
glycosylase 4
T, U, 5-FU, εC,
opposite G, dsDNA
M ko: viable, elevated mutation
frequency (C→T)
TDG Thymine DNA
glycosylase
T, U, 5-FU, εC,
5-hmU, 5-fC, 5-caC;
opposite G, dsDNA
M ko: embryonic lethal, aberrant DNA
methylation and imbalanced
chromatin marks in CpG-rich
promoters
Oxidative base
damage
OGG1 8-OxoG DNA
glycosylase 1
8–oxoG, FaPy,
opposite C, dsDNA
B ko: viable, accumulation of 8-oxoG,
elevated mutation frequency (G→T)
MYH MutY homolog DNA
glycosylase
A opposite 8–oxoG, C
or G, 2–hA opposite
G, dsDNA
M ko: viable, see OGG1
Alkylated purines MPG Methylpurine
glycosylase
3–meA, 7-meG, 3-
meG, hypoxanthine,
εA, ss and dsDNA
M ko: viable, elevated levels of ethenoA
and hypoxanthine
Oxidized,
ring-fragmented
or –saturated
pyrimidines
NTHL1 Endonuclease III-like 1 Tg, FaPyG, 5-hC,
5-hU, dsDNA
B ko: viable
NEIL1 Endonuclease VIII-like
glycosylase 1
Tg, FaPyG, FaPyA,
8-oxoG, 5–hU, 5–
hC, ss and dsDNA
B ko: metabolic syndrome, increased
damage levels in mitochondrial DNA;
kd: hypersensitive to γ radiation
NEIL2 Endonuclease VIII-like
glycosylase 2
As NTHL1 and
NEIL1
B Unknown
NEIL3 Endonuclease VIII-like
glycosylase 3
FaPyG, FaPyA,
prefers ssDNA
B ko: normal
U, uracil; , A, adenine; , T, thymine; , C, cytosine, G, guanine; , ss single stranded; , ds, double stranded; , 5–hm, 5–hydroxymethyl; , 5-FU, 5-
fluorouracil; , ε, etheno; , 5-fC, 5-formylcytosine; , 5-caC, 5-carboxylcytosine; , 8–oxoG, 8–oxo-7,8-dihydroguanine; , Tg, thymine glycol; , FaPy,
2,6-diamino-4-hydroxy-5-N-methylformamidopyrimidine; , me, methyl; , h, hydroxyl
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(Neddermann et al. 1996). Crystal structural analyses
revealed a striking resemblance in the overall fold of the
glycosylase domains of E.coli Mug and Ung, despite the
absence of a notable sequence similarity (Barrett et al. 1998).
Unlike UNG, however, the MUG glycosylases have a
spacious and rather non-discriminating active site pocket,
accommodating a broad range of substrates including
pyrimidine derivates like 5-FU, 5-hydroxymethyluracil (5-
hmU), and 3,N4-ethenocytosine (Table 1) (reviewed in
Cortazar et al. 2007), and they process these substrates with
an extremely low turnover rate (Waters and Swann 1998;
Hardeland et al. 2000). Compared to E.coli Mug, which
consists of the catalytic core only, TDG contains additional
N- and C-terminal domains, providing non-specific DNA
interaction and regulatory functions (Hardeland et al. 2002;
Steinacher and Schär 2005; Baba et al. 2005). Knockout of
Tdg in mouse is embryonic lethal, suggesting that, unlike
other UDGs, it has a non-redundant essential function in
embryonic development (Cortazar et al. 2011; Cortellino et al.
2011). TDG-deficient cells do not show increased sensitivity
towards agents that would cause TDG-relevant DNA base
lesions, nor do they show increased levels of spontaneous
mutations (Cortazar et al. 2011), implicating functions
beyond canonical DNA repair, which will be discussed
below. An involvement of TDG in DNA repair becomes
obvious, however, in the processing of the anti-cancer drug
5-FU when incorporated into the DNA. In this special case,
the repair activity of TDG does not provide drug resistance
as might be expected; excision of the base analog by TDG
results in an accumulation of toxic AP-site intermediates and
DNA strand breaks and, thus, mediates the DNA-directed
cytotoxic effect of 5-FU (Kunz et al. 2009b).
SMUG-family glycosylases were initially identified as
a uracil-excising activity in Xenopus, insect, and human
cells (Haushalter et al. 1999). As such, it appears to serve
as back-up for UNG in limiting uracil accumulation (U•A)
in genomic DNA and in preventing C→T mutation
following cytosine deamination (U•G) (Haushalter et al.
1999; An et al. 2005). While Xenopus SMUG has a
preference for uracil in single-stranded DNA, hence the
name “single-strand-specific monofunctional uracil DNA
glycosylase”, the human homolog processes uracil also in
double-stranded DNA (Table 1) (Haushalter et al. 1999;
Kavli et al. 2002). SMUGs show only limited amino-acid
sequence similarity with members of other UDG sub-
families and the conservation seems restricted to catalytic
site residues, showing mosaic features of the UNG and
MUG enzymes. Crystallographic analysis of SMUG1
identified a pyrimidine binding pocket topologically
similar to other UDGs and implicated a water displace-
ment/replacement mechanism to account for the enzyme's
preference for uracil over thymine (Wibley et al. 2003).
Like TDG, SMUG1 is active on 5-FU but, unlike TDG,
appears to protect cells from the cytotoxic effects of the
drug as shown in siRNA knockdown experiments (An et
al. 2007). Notably, a 5-hmU DNA glycosylase activity
originally discovered in calf thymus was later identified as
SMUG1 (Cannon-Carlson et al. 1989; Boorstein et al.
2001). So, like TDG, SMUG1 is capable of processing the
deamination product of 5-hydroxymethylcytosine (5-
hmC), a substrate that has recently gained attention in
the context of active DNA demethylation.
Additional subfamilies of UDGs appear to have
evolved in archaeal and bacterial organisms thriving
under extreme environmental conditions such as high
temperature, favoring hydrolytic deamination of cytosine
and 5-meC. As these will not be further discussed here,
the reader is referred to the excellent classification of the
UDG superfamily originally published by Aravind and
Koonin (2000).
The helix-hairpin-helix glycosylases
The second superfamily of DNA glycosylases, charac-
terized by a shared helix-hairpin-helix (HhH) domain,
comprises a diverse group of enzymes present in
organisms throughout all kingdoms of life. Phylogenetic
analysis in 94 genomes from bacteria, archaea, and
eukaryotes identified six distinct families of HhH DNA
glycosylases: Nth (homologs of the E. coli EndoIII
protein), OggI (8-oxoG DNA glycosylase I), MutY/Mig
(A/G-mismatch-specific adenine glycosylase), AlkA
(alkyladenine-DNA glycosylase), MpgII (N-methylpur-
ine-DNA glycosylase II), and OggII (8-oxoG DNA
glycosylase II) (Denver et al. 2003). The Nth and MutY/
Mig family glycosylases as well as some of the MpgII
type proteins contain iron–sulfur [4Fe4S] clusters that are
thought to play a structural role in DNA binding and
substrate recognition (Cunningham et al. 1989; Kuo et al.
1992; Guan et al. 1998; Porello et al. 1998; Begley et al.
1999).
The founding member of the Nth family was originally
discovered as an endonuclease activity (EndoIII) in E.coli
(Radman 1976) but then turned out to be a DNA glycosylase
with an associated AP-lyase activity. Nth proteins appear to
be the most highly conserved subfamily within the HhH
glycosylases (Denver et al. 2003). The mammalian homolog,
NTHL1 (endonuclease III-like 1), acts on ring fragmented
purines or oxidized pyrimidine residues like thymine glycol
(Tg), formamidopyrimidine (FaPy), 5-hydroxycytosine (5-
hC), and 5-hydroxyuracil (5-hU), preferentially when placed
opposite guanine (Table 1) (Dizdaroglu et al. 1999; Eide et al.
2001). Nth1 knockout mice show no overt abnormalities
presumably because the loss of its repair function can be
compensated for by NEIL glycosylases (see below) (Ocampo
et al. 2002; Takao et al. 2002).
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MutY was first identified in E.coli as an enzyme
excising adenine from A•G mispairs (Au et al. 1988),
while Mig.Mth was discovered in hyperthermophilic
archaea by its ability to excise U or T mispaired with G
(Horst and Fritz 1996). MutY/Mig homologs are wide-
spread in bacterial genomes, but only about half of the
eukaryotes and less than a third of the archaeal species
analyzed have glycosylases of this family (Denver et al.
2003). The mammalian homolog of MutY, termed MYH,
excises adenine opposite 8-oxoG, guanine, or cytosine
(Table 1) (McGoldrick et al. 1995), contributing to a
multimodal defense against the mutability of guanine
oxidation (van Loon et al. 2010). Facilitating the replace-
ment of A opposite 8-oxoG with a C, MYH produces the
preferred substrate for the 8-oxoG directed DNA glyco-
sylase OGG1. Hence, disruption of Myh in mice does not
produce a mutator phenotype per se because it is masked
by OGG1, which corrects the bulk of oxidized guanines
before replicative DNA polymerases get a chance to
misinsert adenine opposite the damaged base. Knocking
out both Myh and Ogg1, however, results in a synergistic
increase in G→T mutations (Russo et al. 2004). In humans,
germline mutations in the MYH gene have been associated
with a predisposition to colorectal cancer (Al-Tassan et al.
2002; Jones et al. 2002).
The Ogg1 protein family is less well represented across
the phylogeny. While present in most eukaryotic genomes,
Ogg1 encoding genes seem to be missing in bacteria and
archaea (Denver et al. 2003). Ogg1 was originally
discovered in yeast and later also identified in mammals
(Nash et al. 1996; Lu et al. 1997; van der Kemp et al. 1996;
Radicella et al. 1997), where it provides the major activity for
the removal of 8-oxoG opposite cytosine (Friedberg et al.
2006). It does, however, also excise other oxidized pyrimi-
dines or ring-fragmented purines like formamidopyrimidine
(FaPy) (Table 1) (Dherin et al. 1999; Karahalil et al. 1998).
In Saccharomyces cerevisiae, inactivation of OGG1 results
in an accumulation of G→T transversion mutations
(Thomas et al. 1997). Ogg1 null mice are viable but
exhibit a 2-fold increase in chromosomal 8-oxoG and
moderately elevated spontaneous mutation frequencies
(Klungland et al. 1999). Polymorphisms in the human
OGG1 gene impairing the 8-oxoG incision activity were
found to be associated with non-small cell lung cancer (Janik
et al. 2011) and an increased risk of childhood acute
lymphoblastic leukemia (Stanczyk et al. 2011).
Although closely related to the Nth and MutY proteins,
MBD4, also known as MED1, is special in two ways; it has a
methyl-CpG binding domain (MBD) and is therefore also a
member of the MBD protein family, and it functionally
interacts with MLH1, a protein of the postreplicative
mismatch repair system (Hendrich and Bird 1998; Bellacosa
et al. 1999). Like the structurally unrelated TDG, MBD4 is a
mismatch-directed DNA glycosylase processing a wide
range of G-mispaired base lesions, including thymine, uracil,
5-FU, and 3,N4-ethenocytosine (Table 1) (Petronzelli et al.
2000; Cortellino et al. 2003). Its methyl-CpG binding
domain in addition to its activity on the deamination product
of 5-meC has made MBD4 a prime candidate for an active
DNA demethylase, an epigenetic function likely to be
important in embryogenesis. However, Mbd4 knockout mice
show no developmental defects, but a mild increase in C→T
mutation frequency and a predisposition to gastrointestinal
cancer in APC-deficient tumor models (Millar et al. 2002;
Wong et al. 2002), consistent with a role of MBD4 in repair
of cytosine or 5-meC deamination damage.
E.coli AlkA, the founding member of the AlkA family
of HhH glycosylases, acts on alkylated bases, e.g., 3-meA.
While homologs are present in many bacterial and
eukaryotic genomes (Denver et al. 2003), mammals appear
to be devoid of this particular class of enzyme. Instead, they
use a structurally unrelated enzyme, MPG, to eliminate
specific forms of base alkylation damage.
The 3-methyl-purine glycosylase (MPG)
MPG, also known as AAG or MDG, originally identified in
rat (O'Connor and Laval 1990) and later in human, is a
DNA glycosylase excising a range of alkylated bases from
DNA, including 3-meA, 7-meG, 3-methylguanine (3-meG)
as well as ethylated bases in single- and double-stranded
DNA (Table 1) (O'Connor 1993; Lee et al. 2009). MPGs
form a structurally distinct class of glycosylases; they lack
helix-hairpin-helix motifs nor do they have an alpha–beta
fold structure characteristic of UDGs. Mice lacking MPG are
viable and show a mild increase in the frequency of
spontaneous mutation (Engelward et al. 1997; Hang et al.
1997), and they are more prone to develop azoxymethane-
induced colon cancer than their wild-type counterparts (Wirtz
et al. 2010). Reminiscent of TDG’s role in the DNA-directed
cytotoxic effect of 5-FU, MPG drives alkylation-induced
retinal degeneration in mice by generating cytotoxic BER
intermediates (Meira et al. 2009).
The endonuclease VIII-like glycosylases
Although their substrate spectrum overlaps with that of
endonuclease III (Nth), the homologs of E. coli endonuclease
VIII, encoded by the nei gene, are structurally related to the
formamidopyrimidine-DNA glycosylase Fpg and form a
separate family of DNA glycosylases. Nei was discovered in
E. coli as a second activity next to Nth acting on thymine
glycol (Tg) and urea (Melamede et al. 1994).
The mammalian counterparts are termed Nei-like
(NEIL)1, 2, and 3, and share a conserved helix-two-turn-
helix motif with the E. coli Fpg and EndoVIII proteins. The
Chromosoma (2012) 121:1–20 5
preferred substrates of NEIL1 and NEIL2 are oxidized
pyrimidines such as Tg, 5-hC, FaPyA, and FaPyG (Hazra
et al. 2002; Morland et al. 2002; Rosenquist et al. 2003),
but also 5-hydroxyuracil (5-hU) and 8-oxoG in DNA
bubble structures (Table 1) (Dou et al. 2003). NEIL3, on
the other hand, excises FaPy but is inactive on 8-oxoG
(Liu et al. 2010). Mice with a targeted inactivation of the
Neil1 gene exhibit a phenotype reminiscent of the
metabolic syndrome, as well as increased levels of DNA
damage in mitochondrial DNA (Vartanian et al. 2006).
Neil3 knockout mice are viable and fertile, and the protein
appears to be preferentially expressed in hematopoietic
tissues (Torisu et al. 2005), implicating a possible function
in hematopoiesis or the immune system.
Structure function aspects
DNA glycosylases evolved to counter the many different
forms of chemical damage occurring to DNA bases. They
are highly specialized enzymes with distinct structures and
substrate specificities, but they all share a common
principle of action. DNA glycosylases recognize their
cognate substrates by rotating bases out of the DNA helix
into a specifically fitting pocket that harbors the active site.
Substrate selectivity is mostly achieved by steric exclusion
from the binding pocket of bases that are not to be
processed, and to some extent also by the catalytic
efficiency of the active site configuration. If base fitting is
successful, cleavage of the N-glycosidic bond will occur,
resulting in the release of a free base and the generation of a
base-less sugar, an AP-site in the DNA.
Detection and verification of base damage
Detecting a single damaged base in a vast excess of regular
bases in the genome amounts to the proverbial task of
searching a needle in a haystack, and this is not helped by
the fact that the lesions addressed by BER do not usually
cause notable distortions to the DNA helix. A human cell
suffers about 104 base lesions per day, translating into
roughly one lesion every 10 s within a genome of about
14 billion nucleotides that must be spotted and repaired.
How DNA glycosylases manage to efficiently search for
and recognize these lesions is not clear but biochemical and
structural work has provided some insight into possible
mechanisms.
Scanning the genome for damaged bases
Little is known about how DNA glycosylases find damaged
bases in the genome. One idea, proposed on the basis of
biochemical evidence and theoretical considerations, postu-
lates the association of the glycosylase with undamaged
DNA by non-specific interactions, facilitating sliding along
the DNA duplex for a certain distance and scanning the
sequence for irregular bases (Berg et al. 1981). Considering
the structural and functional diversity of DNA glycosylases,
however, there are likely to be different translocation
mechanisms, variably involving features of tracking, diffu-
sion, and hopping on the DNA (Blainey et al. 2009;
Steinacher and Schär 2005; Friedman and Stivers 2010).
Recently, an appealing DNA scanning concept was pro-
posed for DNA glycosylases harboring an [4Fe4S] cluster.
The underlying observation was that E. coli MutY and Nth
change the oxidation state of their iron–sulfur cluster from
[4Fe4S]2+ to [4Fe4S]3+ upon contact with DNA, which
stabilizes the interaction. Thus, if such DNA glycosylases
bind in the vicinity of each other, they might act as electron
donors and acceptors for each other, making use of the
DNA for charge transfer. This may facilitate the dissocia-
tion of one glycosylase upon binding of another by
reduction of its [4Fe4S] cluster. If the electron transfer
involved is perturbed by a base lesion between the two
glycosylases, however, both will stay bound to the DNA,
increasing the likelihood of damage detection (Boal et al.
2009). This way, [4Fe4S] clusters may support the search
for base damage without a need of scanning the entire DNA
sequence.
Detection of DNA base damage by DNA glycosylases
ultimately requires a full examination of the chemical
surface of single bases. To minimize the effort, DNA
glycosylases employ strategies of damage pre-selection.
OGG1 and UNG, for instance, were proposed to pre-select
substrates by establishing superficial base contacts through
conserved residues in close proximity to the mouth of their
catalytic pocket. This allows potential substrates to be
identified without fully inserting every base into the active
site pocket (Fig. 2) (Banerjee et al. 2005; Parker et al.
2007). Consistently, NMR studies on human UNG showed
the glycosylase to undergo a conformational change upon
DNA binding, allowing for oscillation between an open
form, loosely interacting with the DNA in an unspecific
manner, and a closed form engaged in base examination
without fully rotating the base out of the helix (Fig. 2)
(Friedman et al. 2009). Base pre-scanning is likely to be
facilitated by DNA breathing, considering that many base
lesions affect base pairing dynamics to some extent and are
therefore likely to enhance local DNA melting.
Formation of a mature enzyme substrate complex
For final damage verification, the base needs to be flipped
out of the DNA helix and accommodated in the active site
cavity of the glycosylase. This increases the surface for
molecular interactions, providing for a sensitive discrimi-
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nation of even minor base alterations and, ultimately,
catalysis of the base release. One of the best-studied
glycosylases with regard to damage recognition is UNG.
On its surface, UNG forms a positively charged groove that
accommodates the minor groove of the DNA and contains
the active site cavity. Upon encountering a uracil in DNA,
UNG uses a hydrophobic side chain of a conserved leucine
to push the uracil out of the base stack and insert it into the
catalytic pocket (Fig. 3). The same residue stabilizes the
double helix by occupying the vacated space (Mol et al.
Fig. 2 Mechanism of base removal by monofunctional and bifunc-
tional glycosylases. While all DNA glycosylases share a common
principle of action, they differ in details of damage search,
recognition, and excision. Among the monofunctional DNA glyco-
sylases, UNG searches for uracil in DNA by oscillating between an
open conformation, making unspecific contacts with the DNA, and a
closed conformation for base-interrogation (a), involving conserved
structures at the mouth of the catalytic site pocket (b). Pre-selected
bases are flipped out of the DNA duplex and inserted into the catalytic
pocket, where specific hydrogen bonds align the base for nucleophilic
attack by an activated water molecule strategically positioned by a
conserved aspartic acid residue (red asterisk, c). TDG differs from
UNG by its non-specific interaction with DNA through a clamp
formed by the N-terminal domain (a), its larger catalytic pocket that
accommodates a broader range of substrates, and its ability to involve
the opposing base in lesion recognition (b). The catalytic residue in
TDG is an asparagine (black asterisk) that positions, but does not
activate, a water molecule which can then act as a weak nucleophile
(c). TDG stays firmly bound to the abasic site upon base release (d)
until SUMOylation induces dissociation by neutralizing the N-
terminal DNA binding activity (e). Similar to UNG, the bifunctional
OGG1 pre-selects bases for flipping by interactions with conserved
amino-acid residues at the mouth of the catalytic cavity (a, b), and
similar to TDG, it also takes the opposing base into account for
substrate selection (c). Bifunctional glycosylases use a conserved
amino-acid residue (blue asterisk) for nucleophilic attack, which
results in a covalent intermediate between the glycosylase and the
DNA substrate (d). Resolution of this intermediate produces a DNA
nick that is further processed by APE1 (e)
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1995; Savva et al. 1995). At the same time, UNG pinches and
compresses the double-stranded DNA backbone, thereby
inducing DNA bending by about 45° at the site of the damage
(Fig. 1) (Parikh et al. 1998). Selectivity for uracil is mediated
by several structural features: purine bases are sterically
excluded from the active site by the overall narrow geometry
of the binding pocket, while the entry of thymine and other 5-
methylated pyrimidines is blocked by a side chain of a
conserved tyrosine residue. Accordingly, UNG can be
converted into a thymine-processing enzyme by an amino
acid substitution that eliminates this sterical block (Kavli et al.
1996). Cytosine can enter the active site but, due to
unfavorable hydrogen bonding at the bottom of the cavity,
cannot be positioned correctly for catalysis (Kavli et al. 1996;
Slupphaug et al. 1996).
While UNG is highly specialized to the excision of DNA
uracil, TDG is a good example of a broad spectrum UDG
showing mismatch dependency. Unlike UNG, the bacterial
and human TDG orthologs have rather spacious pyrimidine-
binding pockets, accommodating a large variety of base
derivatives (Barrett et al. 1998, 1999; Baba et al. 2005; Maiti
et al. 2008), although the preferred substrates are G-
mismatched deaminated pyrimidines (Waters and Swann
1998; Hardeland et al. 2003). Because TDG acts on thymine,
it needs to be able to discriminate between a regular thymine
in DNA (A•T) and one that resulted from deamination of 5-
meC (G•T). Substrate selection thus has to take into account
not only the base structure itself but also the opposite base.
Structural and biochemical studies of E.coliMug and human
TDG (Barrett et al. 1998; Maiti et al. 2008, 2009) have shed
light on how this might be achieved. In contact with DNA,
TDG undergoes a conformational change in its N-terminal
domain, forming a clamp-like structure that permits TDG to
track along the DNA (Fig. 2) (Steinacher and Schär 2005).
Upon encountering a G-mismatched substrate (G•T), the
substrate base is pushed out of the DNA helix by an insertion
loop wedging into the DNA helix. This same wedge
stabilizes the base stack and forms specific hydrogen bonds
with the widowed guanine, mimicking Watson–Crick base
pairing (Barrett et al. 1998, 1999; Maiti et al. 2008). These
interactions then cooperate with the non-specific DNA
binding activity of the N terminus to stabilize the TDG–
substrate complex for efficient base excision (Hardeland et al.
2000; Steinacher and Schär 2005).
Another DNA glycosylase well studied with regard to
damage recognition is OGG1. Following successful pre-
selection of a potential 8-oxoG substrate (Fig. 2) (Banerjee
et al. 2005), the oxidized base is flipped into the active site
cavity of OGG1, inducingDNAbending of about ~70° due to a
tyrosine residue that wedges between the opposing C and its 5′
neighbor. Unstacking of the widowed C facilitates enzyme–
DNA contacts that maintain opposite base selectivity. The void
generated by 8-oxoG rotation is occupied by a conserved
asparagine residue, which contributes to hydrogen bonding
with the opposing cytosine. While A, C, and T are excluded
from the active site pocket by several strategically positioned
amino-acids, a conserved glycine is the only residue discrim-
inating between G and 8-oxoG (Bruner et al. 2000).
Catalysis of base removal
The catalytic mechanism subdivides DNA glycosylases into
monofunctional and bifunctional enzymes (Table 1). Mono-
functional glycosylases perform base excision only, using
an activated water molecule for nucleophilic attack on the
N-glycosidic bond, while bifunctional glycosylases use an
amino group of a lysine side chain for the same purpose,
forming a Schiff-base intermediate, and subsequently
cleave the DNA backbone 3′ to the lesion.
Monofunctional DNA glycosylases
To illustrate the monofunctional mode of action, we will
focus on UNG and TDG as two well-studied UDGs
Fig. 3 The base-flipping
intermediate captured in a crystal
structure of substrate bound
human UNG. The UNG double
mutant L272R/D145N, stabilizing
the glycosylase–substrate
complex, was co-crystallized with
an oligonucleotide bearing a U•G
mismatch. Uracil (red) is flipped
into an extrahelical position (a)
and inserted deeply into the tight
fitting active site pocket of UNG
(b), where it is positioned by
specific molecular interactions for
the nucleophilic attack on the
N-glycosidic bond (Slupphaug
et al. 1996)
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showing contrasting catalytic features. Upon recognition,
uracil is tightly fitted into the active site pocket of UNG
(Fig. 3). Interactions between the uracil and amino-acid
residues at the bottom of the pocket position the N-glycosidic
bond for hydrolysis (Mol et al. 1995; Savva et al. 1995;
Slupphaug et al. 1996). Structure and mutational analyses
have established a catalytic mechanism involving the
polarization of the N-glycosidic bond by a conserved
histidine to make it susceptible for nucleophilic attack, and
the positioning and deprotonation of a water molecule by a
conserved catalytic aspartate, which then attacks the C1 of
the deoxyribose (Fig. 2) (Mol et al. 1995; Slupphaug et al.
1996). N-glycosidic bond cleavage is completed by addition
of the water nucleophile to uracil, resulting in a free base and
an AP-site.
The mismatch-specific uracil glycosylases, e.g., Mug
and TDG, interact less specifically with the substrate
base within the catalytic pocket and use a less potent
mechanism of catalysis, as first revealed in the crystal
structure of E.coli Mug (Barrett et al. 1998, 1999). In
place of the catalytic aspartate in UNG, Mug/TDG
enzymes have an asparagine. This asparagine positions a
water molecule but, unlike the aspartate in UNG, is
unable to protonate it for an efficient nucleophilic attack
on the N-glycosidic bond (Fig. 2). Also, an appropriate
residue for polarization of the N-glycosidic bond appears
to be missing in Mug/TDG, altogether explaining the
comparably low catalytic efficiency of the MUG enzymes
(Hardeland et al. 2000; Maiti et al. 2009). These differ-
ences illustrate that the mode of catalysis can vary
considerably even within one DNA glycosylase super-
family, most likely reflecting the requirement to fine tune
substrate spectrum and catalytic efficiency in the evolu-
tion of subfamilies with distinct biological functions.
Bifunctional DNA glycosylases
DNA glycosylases that use an amino group of a lysine
side chain as a nucleophile for base cleavage form a
covalent Schiff-base intermediate with the substrate. The
resolution of this reaction intermediate incises the DNA
3′ to the product AP-site, generating a strand break with
3′phosphate and 5′OH ends. Thus, these enzymes couple
base excision with an AP-lyase step, as best illustrated
by the bifunctional mechanism proposed for OGG1 (Sun
et al. 1995; Nash et al. 1997). Once an 8-oxoG is stably
fitted in the active site cavity of OGG1, the side chain amino
group of a suitably positioned catalytic lysine is activated as a
nucleophile to attack the C1 of the deoxyribose. The resulting
rearrangement to a covalent Schiff-base intermediate releases
the damaged base from the DNA, which is then held in
position to further participate in the catalysis of the β-lyase
reaction, cleaving the DNA strand at the 3′phosphate. Notably,
all steps of the OGG1 catalyzed base release involve the
transfer of protons and this is promoted by the excised base
itself (Bruner et al. 2000; Fromme et al. 2003). An interesting
variation on the bifunctional mode of action is displayed by
the mammalian NEIL proteins and their E.coli counterpart
Nei. These enzymes couple base excision to beta and delta
elimination, incising the DNA strand both 3′ and 5′ to the
AP-site (Takao et al. 2002). Moreover, unlike OGG1, E. coli
Nei ejects the excised base from the catalytic site immedi-
ately, i.e., is capable to perform the AP-lyase reaction without
contribution of the damaged base (Zharkov et al. 2002).
AP-site dissociation and turnover of glycosylases
Upon base release, DNA glycosylases tend to stay bound to
the product of their action, the AP-site. In fact, many
glycosylases display a higher affinity to AP-sites than to
their actual substrate base (Parikh et al. 1998; Waters et al.
1999; Hardeland et al. 2000; Hill et al. 2001; Pope et al.
2002). The release of the glycosylase from the AP-site is
thus rate limiting in the BER process (Fig. 1). Since AP-
sites are chemically unstable and lack base coding potential,
the binding of the glycosylase might serve to protect cells
against their cytotoxic and mutagenic effects. This consid-
ered, it appears reasonable that the release of the AP-site is
coordinated with the recruitment and assembly of the
downstream acting BER factors. Consistently, the AP-
endonuclease APE1 was reported to stimulate the turnover
of several DNA glycosylases including UNG2, TDG, and
OGG1 (Parikh et al. 1998; Waters et al. 1999; Hill et al.
2001), and a similar effect was observed for the XPC
protein on TDG and SMUG1 (Shimizu et al. 2003, 2010).
It remains to be clarified, though, to what extent these
stimulatory effects reflect active processes or simply a
passive competition for a common DNA substrate.
Another, perhaps more sophisticated, way to regulate
AP-site interaction of the glycosylase is by posttransla-
tional modification. In this direction, UNG2 was reported
to be cell cycle specifically phosphorylated at serine 23,
which markedly increases its association with replicating
chromatin but also its turnover rate, apparently to
facilitate efficient correction of misincorporated uracil
during ongoing DNA replication (Hagen et al. 2008). In
the case of TDG, which binds AP-sites very rigidly,
dissociation is regulated by modification of a C-terminal
lysine residue with small ubiquitin-like modifiers
(SUMOs). This induces a conformational change that
neutralizes the non-specific DNA-binding capacity of its
N-terminal domain, thereby facilitating AP-site dissocia-
tion (Fig. 2) (Hardeland et al. 2002; Steinacher and Schär
2005). SUMO modification might be triggered by the
presence of downstream acting BER factors, providing for
a controlled handover of the AP-site intermediate in the
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repair process (R. Steinacher and P. Schär, unpublished
data).
It appears to be a general feature of DNA glycosylases to
bend DNA upon establishing a mature enzyme–substrate
complex; UNG for example induces a bend of ~45° (Parikh
et al. 1998), OGG1 of even ~70° (Bruner et al. 2000). On the
basis of these and similar observations with other BER
factors, it was proposed that the DNA bending might serve as
a structural determinant to orchestrate the handover from one
step in the repair process to the next (Fig. 1) (Parikh et al.
1999; Wilson and Kunkel 2000).
Functions of DNA glycosylases beyond DNA repair
Although DNA glycosylases are optimally suited for the repair
of damaged DNA bases, their structural and biochemical
properties would support a much wider spectrum of genetic
functions. The ability to recognize and excise chemically
modified bases can be used to edit the DNA at specifically
marked sites. The UDG superfamily in particular appears to
comprise enzymes with specialized functions, e.g., in innate
immunity and antibody diversification, as well as in the
regulation of gene expression and epigenetic maintenance.
DNA glycosylases in immunity
UDGs haven been functionally associated with mechanisms
providing innate immunity against viral infection as well as
antibody diversity in the adaptive immune system. All these
processes are triggered by enzymatic deamination of
cytosine by members of the apolipoprotein B mRNA
editing catalytic polypeptide (APOBEC) family of proteins,
including the activation-induced cytidine deaminase (AID)
(Conticello et al. 2005).
DNA glycosylases providing innate immunity
Proteins of the human APOBEC3 subfamily were shown to
inhibit replication of a variety of retroviruses, including
human immunodeficiency viruses (HIV) (reviewed in
Holmes et al. 2007). APOBEC3G was discovered by its
ability to restrict replication of a mutant HIV-1 lacking the
viral infectivity factor (Vif) (Sheehy et al. 2003). Cells
infected with such a virus package APOBEC3G into HIV-1
virions. When these infect new cells, APOBEC3G will
deaminate multiple cytosines in the viral cDNA during
reverse transcription, which inactivates the provirus
(reviewed in Holmes et al. 2007). While APOBEC3G
appears to intervene with the viral life cycle at several steps,
the antiviral activity mediated by uracilation of the viral
genome is coupled to the action of UNG2 and APE1.
UNG2 is thought to introduce AP-sites into the deaminated
viral cDNA, triggering the cleavage and thus degradation by
APE1 (Harris et al. 2003; Yang et al. 2007). Consistently,
inhibition and/or downregulation of either UNG2 or APE1
was shown to decrease the antiviral potency of APOBEC3G
(Yang et al. 2007). Given that HIV-1 evolved Vpr, a small
protein specifically targeting UNG2 and SMUG1 for
degradation by the ubiquitin–proteasome system, supports a
critical role of uracil base excision in antiviral defense
(Schrofelbauer et al. 2005, 2007).
DNA glycosylases providing adaptive immunity
The cooperation of cytidine deaminase and UDG activities is
also central to the genetic transactions associated with
antibody diversification in the adaptive immune system, i.e.,
somatic hypermutation (SHM) and class switch recombina-
tion (CSR) (Fig. 4) (Muramatsu et al. 2000; Rada et al.
2002).
SHM introduces point mutations in the light chain
variable (V) region of immunoglobulin loci. Mutagenesis
is initiated by AID, which is targeted to these loci to
deaminate multiple cytosines in single-stranded DNA
occurring during transcription (reviewed in Pavri and
Nussenzweig 2011). Mutations can arise from these U•G
mismatches in several ways (Fig. 4): (1) in the absence of
uracil excision, replication across the U•G mismatch would
generate a C→T mutation in one of the daughter strands;
(2) uracil excision by a UDG and subsequent replication
across the resulting AP-site can potentially give rise to any
type of base substitution at the site of deamination,
although replicative DNA polymerases preferentially insert
A opposite an AP-site; (3) long-patch BER, initiated by a
UDG, or MMR coupled to error-prone DNA synthesis
would cause mutations in proximity to the deaminated
cytosine, allowing for mutations to occur also at A•T base
pairs.
An involvement of UNG2 in antibody diversification
was first implicated by a general perturbance of both SHM
and CSR in an UNG2 inhibited chicken B-cell line as well
as in UNG-deficient mice (Di Noia and Neuberger 2002;
Rada et al. 2002). While the loss of UNG mainly affected
SHM at G•C base pairs, inactivation of the mismatch repair
system (MMR) was found to diminish hypermutation
at A•T pairs (Rada et al. 1998; Wiesendanger et al. 2000).
This suggested that error prone MMR contributes to muta-
genesis at sites away from the deaminated cytosine (Wilson et
al. 2005). Later work then implicated that MMR can indeed
operate at an AID induced G•U mismatch if assisted by
UNG2, providing a nick at a nearby G•U for initiation of
strand excision (Frieder et al. 2009; Schanz et al. 2009).
AID, UNG2, and APE1 were also shown to play a
crucial role in the initiation of CSR, a specialized
recombination process switching the Ig isotype of an
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Fig. 4 Uracil DNA glycosylase in antibody diversification. UNG
plays a central role in somatic hypermutation (SHM) and class switch
recombination (CSR). UNG2 is targeted to immunoglobulin loci in
activated B-cells by AID converting cytosine to uracil in single-
stranded DNA during transcription. While replication across unpro-
cessed uracil itself will generate C→T mutations, uracil excision by
UNG provides for a wider range of mutations both at the C•G and
nearby A•T base pairs; (1) by generating non-instructive AP-sites
which, upon DNA replication give rise to transition or transversion
mutations, (2) by initiating long-patch BER or, (3) following cleavage
by APE1, by providing a DNA strand nick for activation of MMR.
Error-prone synthesis associated with long-patch BER and MMR
would then produce mutations at A•T base pairs. Similarly, DNA
strand breaks occurring through BER of deaminated cytosines in
switch regions of immunoglobulin heavy chain loci may induce CSR
(blue panel)
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antibody without affecting its antigen specificity. CSR
rearranges the antibody constant region of heavy chain
genes (CH) by strand breakage in and joining of two
selected switch (S) regions located upstream of every CH-
coding segment. The DNA strand breaks required for
initiation of CSR were shown to arise through cytosine
deamination, subsequent uracil excision, and AP-site
cleavage by AID, UNG2, and an AP-endonuclease,
respectively (Fig. 4) (Imai et al. 2003). Consistently, murine
B-cells lacking UNG2 show a severe reduction of CSR and
in humans, recessive mutations in the UNG gene have been
associated with the hyper-IgM syndrome caused by a
deficiency in CSR (Rada et al. 2002; Imai et al. 2003). It is
also reported, however, that the catalytic activity of UNG2 is
dispensable for efficient CSR, while an N-terminal sequence
motif appears to be important, suggesting that UNG2 is not
responsible for the DNA cleavage step of CSR (Begum et al.
2007, 2009). It is possible that UNG2 simply marks AID-
induced G•U mismatches for further processing by other
factors, whereby the N terminus is required to mediate
specific protein–protein interactions.
Residual CSR and SHM in UNG2-deficient mice hint at
a possible contribution of other UDGs. Indeed, over-
expression of SMUG1 in MSH2 UNG2 double-deficient
cells could partially restore SHM and CSR. A biological
role of SMUG1 in antibody diversification, however, is
questionable as it is downregulated upon B-cell activation
(Di Noia et al. 2006). Likewise, the U•G mismatch-directed
glycosylase MBD4 is unlikely to play a major role in either
SHM or CSR as a knockout of the gene in mouse showed
no effect on either processes (Bardwell et al. 2003). The
situation is less clear for TDG. While the impact of a TDG-
deficiency on antibody diversification remains to be
investigated, its upregulation in activated mouse B-cells
hints at a specific function in B-cell maturation (Christophe
Kunz and Primo Schär, unpublished data). In this context,
TDG might be simply required to prevent mutations at non-
Ig genes arising from mistargeted AID. It might, however,
also directly contribute to SHM and CSR. Considering its
tight interaction with AP-sites, TDG would be optimally
suited to delay processing of these repair intermediates,
thereby favoring error-prone translesion synthesis and
recombination repair.
DNA glycosylases in DNA methylation control
Distinct patterns of DNA methylation and histone mod-
ifications are established during cell lineage restriction to
determine and maintain cell-type-specific gene expression
programs. In mammals, DNA methylation occurs mainly in
the form of 5-meC in CpG dinucleotide sequences and is
controlled by a methylation machinery consisting of both
methylating and demethylating components. While the de
novo establishment and the maintenance of CpG methylation
can be rationalized by the biochemical features of the DNA
methyltransferase (DNMT) activities involved (Hermann et al.
2004), the reverse process of demethylation has remained
elusive. In principle, however, DNA demethylation can be
achieved through active and/or passive mechanisms. Whereas
passive demethylation occurs upon DNA replication with
downregulation or inhibition of the maintenance DNA
methyltransferase, active demethylation describes the enzy-
matic removal of 5-meC and replacement with C. Active
mechanisms have been implicated in several important
biological processes, including the demethylation of the
paternal pronucleus in the murine zygote (Mayer et al.
2000; Oswald et al. 2000), the genome-wide methylation
erasure and reset of parental imprinting during gametogenesis
(Monk et al. 1987; Kafri et al. 1992), and the reprogramming
of methylation patterns observed after transfer of somatic cell
nuclei to enucleated oocytes (Dean et al. 2001; Simonsson
and Gurdon 2004). Active demethylation has also been
reported to be targeted to select gene regulatory regions
during neurogenesis, memory formation, and immune re-
sponse (Bruniquel and Schwartz 2003; Miller and Sweatt
2007; Ma et al. 2009).
Mechanistically, the conversion of 5-meC to C in DNA
can occur in different ways: (1) by a direct removal of the
methyl group, (2) the replacement of 5-meC with C by
excision repair, or (3) the deamination or oxidation of 5-
meC followed by replacement of the nucleotide by BER.
Consistent with an excision repair scenario, an increasing
number of observations point at an engagement of DNA
glycosylases in active demethylation. In plants, the removal
of 5-meC by at least four bifunctional DNA glycosylases is
well established; ROS1, DEMETER (DME), and the DME-
like (DML) 2 and 3 all process 5-meC in CpG and non-
CpG sequence contexts (reviewed in Zhu 2009). Mutations
in these glycosylases affect cytosine methylation at specific
loci but not in the overall genome, suggesting that they act
in a targeted rather than a global manner (Penterman et al.
2007; Lister et al. 2008). In vertebrates, the situation is less
clear; MBD4 and TDG have been implicated in DNA
demethylation but they do not seem to be potent enough to
excise 5-meC directly.
Concepts of DNA glycosylase-mediated demethylation
in vertebrates
First evidence for an involvement of DNA glycosylases in
active demethylation in vertebrates came with the discovery
of a 5-meC DNA glycosylase activity in extracts of chicken
embryos (Jost et al. 1995). The responsible enzyme later
revealed itself as a homolog of the human TDG (Zhu et al.
2000b). 5-meC DNA glycosylase activity was then also
reported for the human TDG and MBD4 proteins by the
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same group (Zhu et al. 2000a, 2001). Yet, as several
attempts to reproduce these finding were unsuccessful, the
idea of TDG and MBD4 acting as demethylating glyco-
sylases did not achieve broad acceptance. Recent observa-
tions, however, indicate that the difficulty in reproduction
might lie in the necessity of unknown co-factors that either
boost the catalytic efficiency of these glycosylases or
convert 5-meC into a more favorable substrate.
MBD4 was recently reported to control CpG methylation
in the context of parathyroid (PTH) hormone-induced gene
activation. This was shown for the CYP27B1 promoter,
which undergoes active demethylation upon hormone
stimulation (Kim et al. 2009). Both promoter activation
and cytosine demethylation coincided with and depended on
the physical association of MBD4 and downstream BER
factors, but not of the functionally related TDG. Remarkably,
this study further showed that phosphorylation of MBD4 by
PKC may potentiate its activity to process 5-meC, suggesting
that posttranslational modification might be required to
unleash a potentially harmful but dormant 5-meC glycosylase
activity in certain DNA glycosylases for targeted demethyla-
tion under specific conditions (Fig. 5a). This might apply as
well to TDG, given its propensity to posttranslational
modification by SUMOylation (Hardeland et al. 2002),
ubiquitylation (Hardeland et al. 2007), phosphorylation
(Um et al. 1998), and acetylation (Tini et al. 2002). It will
thus be necessary to revisit TDG's activity as a 5-meC
glycosylase under conditions that support the formation of
these posttranslational modifications.
Other lines of investigation support demethylation
scenarios that involve the conversion of 5-meC to more
favorable substrates for DNA glycosylases. Deamination of
5-meC by a cytidine deaminase is one possibility. This
would generate a G•T mismatch that can be acted on by
Fig. 5 Possible pathways of active DNA demethylation involving
BER. Enzymatic removal of 5-meC has been suggested to be
accomplished by different DNA glycosylase mediated mechanisms.
Direct excision of 5-meC by mammalian DNA glycosylases has been
tested with contradicting results, suggesting the possibility that
posttranslational modification might induce a shift in the substrate
spectrum, allowing for the removal of 5-meC. (a) Another possibility
is the enzymatic conversion of 5-meC to substrates more favorable to
DNA glycosylases, such as deamination to thymine (b), hydroxylation
to 5-hydroxymethylcytosine (c) and/or further oxidation or deamina-
tion of 5-hmC to 5-formylcytosine (5-fC) and 5-carboxylcytosine (5-
caC) (d) or 5-hydroxymethyluracil (e), respectively. All these
processes could be accomplished by a cooperation of 5-meC
deaminases like AID, hydroxylases like the TET proteins, and DNA
glycosylases like TDG (G•T, G•5hmU, G•fC, G•caC), MBD4 (G•T, ?)
and possibly SMUG1 (G•T, G•5hmU, ?)
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MBD4 or TDG (Fig. 5b). Along these lines, it was shown
that the estrogen responsive pS2/TFF1 promoter undergoes
cyclic DNA methylation and demethylation during tran-
scriptional activation, involving 5-meC deamination by the
methyltransferase Dnmt3a/b itself and subsequent TDG-
dependent BER (Metivier et al. 2008; Kangaspeska et al.
2008). The demethylation complex also includes the RNA
helicase p68, implicating an RNA component in either
targeting and/or stabilization of the complex, consistent
with previously reported observations on the chicken 5-
methylcytosine DNA glycosylase (Jost et al. 1997; Schwarz
et al. 2000). Additional support for a deamination-coupled
demethylation pathway came from a study in zebrafish
embryos, implicating AID in the deamination of 5-meC and
MBD4 in the excision of the resulting G•T mismatch, as
well as Gadd45 as an auxiliary factor (Rai et al. 2008). The
same concept was adopted more recently to explain TDG-
mediated 5-meC demethylation as it may occur during
somatic differentiation of the developing mouse embryo
(Cortellino et al. 2011). This, however, was mainly inferred
from the co-immunoprecipitation of overexpressed AID and
Gadd45 with TDG and therefore needs to be corroborated by
more direct functional evidence. Finally, an AID-dependent
and, thus, deamination-mediated mechanism has been associ-
ated with global DNA demethylation occurring in primordial
germ cells as well as during the reprogramming of somatic cell
nuclei towards pluripotency (Bhutani et al. 2010; Popp et al.
2010). Obviously, genome-wide 5-meC deamination would
generate massive amounts of G•T mismatches, and all of
these would have to be repaired by the G•T-directed DNA
glycosylases MBD4 or TDG. A strong prediction of a
deamination-based demethylation model is therefore that a
failure of G•T repair would result in genome-wide C→T
mutagenesis. This has not been observed so far in MBD4
and/or TDG-deficient cells (Cortazar et al. 2011) and will
have to be tested more carefully.
The recent discovery of DNA dioxygenases acting on 5-
meC in DNA introduced another conceptual framework for
active demethylation. The principle of oxidative demethy-
lation of DNA bases was first described for the bacterial
DNA repair protein AlkB. AlkB belongs to a large
superfamily of Fe(II)/2-oxoglutarate (2-OG)-dependent
hydroxylases and catalyzes the hydroxylation of N-
methylated bases like 1-methyladenine (1-meA) and 3-
methylcytosine (3-meC), ultimately resulting in demethylation
upon release of the hydroxymethyl moiety as formaldehyde
(Falnes et al. 2002; Trewick et al. 2002). The superfamily of
Fe(II)/2-OG hydroxylases also contains the kinetoplastid
base J binding proteins (JBP). Base J stands for β-D-
glucosyl(hydroxymethyl)uracil, an abundant base in the
genome of kinetoplastida, synthesized through a 5-hmU
intermediate generated by enzymatic hydroxylation of thy-
mine by JBP1/2 (reviewed in Borst and Sabatini 2008).
Computational analyses identified the mammalian oncogenic
TET proteins as close relatives of the JBPs (Iyer et al. 2009).
The ultimate finding that TETs comprise a catalytic domain
capable of catalyzing the oxidation of 5-meC to 5-hmC
uncovered a functional link between these proteins and DNA
methylation, possibly demethylation (Tahiliani et al. 2009; Ito
et al. 2010). Indeed, 5-hmC was suggested to trigger passive
demethylation through inhibition of the maintenance methyl-
transferase DNMT1 (Valinluck and Sowers 2007). Besides
that, 5-hmC might represent an intermediate of active DNA
demethylation through stepwise oxidation of 5-meC coupled
to either excision repair or decarboxylation (Fig. 5d).
Direct excision of 5-hmC by a DNA glycosylase would
seem a plausible scenario (Fig. 5c). A 5-hmC DNA
glycosylase was reported to be active in calf thymus
extracts (Cannon et al. 1988). The responsible protein,
however, has never been purified, nor has 5-hmC glyco-
sylases activity been associated with any known mamma-
lian DNA glycosylase. Given their activity on 5-hmU, TDG
and SMUG1 would seem good candidates for 5-hmC
processing, but recent evidence shows that at least TDG
fails to do so at an appreciable rate (He et al. 2011; Maiti
and Drohat 2011). Thus, while direct 5-hmC excision by
DNA glycosylases may occur and contribute to DNA
demethylation, the underlying enzymatic pathway remains
to be clarified.
Another possible route of demethylation would be the
further conversion of 5-hmC to an intermediate for DNA
glycosylase mediated excision. The deamination of 5-hmC
by a specific deaminase (e.g., AID), for example, would
give rise to 5-hmU mismatched with G (Rusmintratip and
Sowers 2000), which is a substrate for SMUG1 and TDG
(Fig. 5e) (Boorstein et al. 2001; Hardeland et al. 2003;
Cortellino et al. 2011). As discussed above for 5-meC
deamination, however, the concept of demethylation
through a pro-mutagenic 5-hmU intermediate is debatable
as this would require an immensely efficient and accurate
coupling of the deamination and repair processes, particu-
larly in densely methylated DNA sequences, if genome
integrity is to be maintained.
Less problematic in this regard seems a more recently
implicated mode of TET-mediated demethylation. The key
discovery was that TET proteins do not only generate 5-
hmC but can oxidize this intermediate further to 5-
formylcytosine (5-fC), and 5-carboxylcytosine (5-caC) (Ito
et al. 2011), which are good substrates for excision by TDG
(He et al. 2011; Maiti and Drohat 2011) (Fig. 5d). Given
this, a DNA glycosylase-mediated conversion of 5-meC to
C may thus occur without a need to deaminate, i.e., to
generate a mutagenic intermediate. However, such a
pathway would still trigger massive DNA incision activity
in the context of genome-wide active demethylation, which
seems a genetically risky and energetically wasteful way to
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erase an epigenetic mark. A more straightforward way to
eliminate 5-caC under these conditions would be to couple
the 5-meC oxidation cascade with a decarboxylation step to
generate C and CO2 as final products. A 5-caC decarbox-
ylase is thus an activity to watch out for.
G•T-directed DNA glycosylases and epigenetic stability
Active demethylation of 5-meC in mammalian cells occurs
under different circumstances for different purposes, such
as genome-wide epigenetic reprogramming, activation of
tissue-specific genes during embryogenesis, and the main-
tenance of active and bivalent chromatin states during and
after cell-lineage commitment. These circumstances gener-
ate specific demands for a demethylation mechanism (e.g.,
targeting, catalysis, processivity, efficiency) which are most
likely addressed by distinct pathways.
Any of the above considered routes of DNA repair-
mediated active demethylation of 5-meC requires an
enzyme capable of recognizing and excising a cytosine
derivative (5-meC, 5-hmC, 5-caC, T, 5-hmU) in a base
(mis)pairing configuration with guanine. On the basis of
their substrate spectra, the two DNA glycosylases MBD4
and TDG appear to be most suitable for this purpose, and
both have been implicated in one way or another in DNA
demethylation as discussed. The biological functions
associated with these activities, however, still need to be
clarified. Considering, for instance, the reported involve-
ment of MBD4 in hormone-induced promoter demethyla-
tion, and the requirement of such demethylation for
derepression of select genes during embryogenesis, it is
surprising that Mbd4 knockout mice develop normally and
display no apparent epigenetic abnormality (Millar et al.
2002; Wong et al. 2002). So, either promoter demethylation
during embryogenesis is not developmentally important, or
MBD4 is not or only redundantly involved in these
processes. The phenotype of Tdg knockout mice, however,
has provided more direct evidence for an epigenetic
function.
Disruption of TDG in mouse causes embryonic lethality
(Cortazar et al. 2011; Cortellino et al. 2011), most likely
because TDG-deficient cells fail to properly establish and/
or maintain cell-type-specific gene expression programs
during cell lineage commitment (Cortazar et al. 2011). This
phenotype coincides with the occurrence of aberrant
chromatin modifications at promoters of misregulated
genes: a loss of active histone marks (H3K4me2), a gain
of repressive histone marks (H3K9me3, H3K27me3) and,
nota bene, a gradual accumulation of CpG methylation
(Cortazar et al. 2011). Together with evidence for a TDG-
dependent engagement of BER at affected gene promoters
(Cortazar et al. 2011; Cortellino et al. 2011), this suggests
that TDG protects CpG-rich promoters from aberrant
hypermethylation by active demethylation of erroneously
methylated cytosines.
TDG may also contribute to active demethylation of
originally methylated sequences. Tissues of TDG defi-
cient embryos showed hypermethylation at the Alb1
enhancer and the Tat glucocorticoid-responsive unit, both
undergoing demethylation in the process of tissue specific
gene activation (Cortellino et al. 2011). These results can,
however, be interpreted in two ways; while the hyper-
methylation measured in the absence of TDG can indeed
be explained by inefficient active CpG demethylation
during tissue differentiation, it can equally well be
accounted for by a lack of TDG-dependent maintenance
of the unmethylated state following successful active
demethylation through a different pathway. Hence, while
the concept of TDG-mediated active demethylation in the
maintenance of hypomethylated states at CpG-rich gene
promoters is well supported, its potential contribution to
demethylation of methylated sequences requires further
validation.
The functions of MBD4 and TDG in mediating DNA
demethylation are clearly distinct but there might be a
partial overlap; TDG might compensate for the loss of
MBD4 in knockout mice but obviously not vice versa. A
plausible scenario would be that MBD4 is primarily
involved in the demethylation of methylated sequences in
the context of developmental gene activation, whereas
TDG’s function is to protect unmethylated promoter
sequences across the genome from aberrant de novo
methylation. This would be supported by the ability of
MBD4 to bind to methylated CpGs, and the preferential
association of TDG with unmethylated gene promoters.
Conclusion
Given their ability to interrogate the surface of DNA
bases by flipping them out of the helix into a selective
active site pocket, DNA glycosylases represent efficient
tools to specifically recognize unduly modified bases and
eliminate them from the DNA, thereby enforcing genetic
integrity. Yet, while being perfectly equipped to function
in DNA repair, their structure and mode of action could
provide for more. This is supported by accumulating
evidence for non-canonical functions of these DNA-
probing enzymes, the most recent and most intensely
discussed being an involvement in DNA demethylation
and epigenetic control. Further studies will shed light on
the mechanism surrounding the action of DNA glyco-
sylases in such a context, from the signals required for
the temporal and spatial regulation of their action to the
co-factors necessary for efficient base-flipping and
excision.
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